# Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation

> **NCT06107543** · — · COMPLETED · sponsor: **Derince Training and Research Hospital** · enrollment: 94 (actual)

## Conditions studied

- Lidocaine

## Interventions

- **DRUG:** Nebulized Lidocaine
- **DRUG:** Iv Lidocaine

## Key facts

- **NCT ID:** NCT06107543
- **Lead sponsor:** Derince Training and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-06-22
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06107543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06107543, "Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06107543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*